Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person9
LIFECORE BIOMEDICAL, INC. \DE\
Company
IMPACT BIOMEDICAL INC.
Company
ICU MEDICAL INC/DE
Company
Encore Medical, Inc.
Company
VYCOR MEDICAL INC
Company
BIOMERICA INC
Company
ACRO BIOMEDICAL CO., LTD.
Company
PSYENCE BIOMEDICAL LTD.
Company
BirchBioMed Inc.
Company
Primary record7
LIFECORE BIOMEDICAL, INC. \DE\ filed 8-K
Item 8.01 Other Events. As previously disclosed, on September 27, 2026, Lifecore Biomedical, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Lifecore Inc. (“Parent”) and Ha
LIFECORE BIOMEDICAL, INC. \DE\ filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026 , Lifecore Biomedical, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the third quarter and nine
LIFECORE BIOMEDICAL, INC. \DE\ filed 8-K
Item 8.01 Other Events. As previously disclosed, on September 27, 2026, Lifecore Biomedical, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Lifecore Inc. and Hazel Merger
LIFECORE BIOMEDICAL, INC. \DE\ filed SCHEDULE 13D/A
on June 14, 2012, as previously amended by Amendment No. 1 filed October 2, 2012, Amendment No. 2 filed October 17, 2014, Amendment No. 3 filed May 24, 2018, Amendment No. 4 filed April 20, 2021, Amendment No. 5 filed Ja
LIFECORE BIOMEDICAL, INC. \DE\ filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 24, 2026, Lifecore Biomedical, LLC ( Lifecore ), a subsidiary of Lifecore Biomedical, Inc. (the Company ), entered into an Amendment No. 3 to Amended and
LIFECORE BIOMEDICAL, INC. \DE\ filed SCHEDULE 13D/A
on Form 8-K filed with the SEC on September 28, 2026, and (ii) the Shares underlying the Series A Preferred Stock that can be converted by the Reporting Persons, as applicable. A. Legion Partners I As of the date hereof,
LIFECORE BIOMEDICAL, INC. \DE\ filed 8-K
Item 1.01 Entry into a Material Definitive Agreement Merger Agreement On September 27, 2026, Lifecore Biomedical, Inc. (the Company or Lifecore ) entered into an Agreement and Plan of Merger (the Merger Agreement ) by an